Achieve Life Ownership
| ACHV Stock | USD 2.66 0.02 0.75% |
Shares in Circulation | First Issued 1994-03-31 | Previous Quarter 34.5 M | Current Value 34.7 M | Avarage Shares Outstanding 2.7 M | Quarterly Volatility 7.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achieve Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Achieve Stock Ownership Analysis
About 42.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.35. Achieve Life Sciences last dividend was issued on the 31st of July 2020. The entity had 1:20 split on the 31st of July 2020. Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more info on Achieve Life Sciences please contact Richard Stewart at 604 210 2217 or go to https://www.achievelifesciences.com.Besides selling stocks to institutional investors, Achieve Life also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Achieve Life's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Achieve Life's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Achieve Life Quarterly Liabilities And Stockholders Equity |
|
Achieve Life Insider Trades History
About 10.0% of Achieve Life Sciences are currently held by insiders. Unlike Achieve Life's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Achieve Life's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Achieve Life's insider trades
Achieve Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Achieve Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Achieve Life Sciences backward and forwards among themselves. Achieve Life's institutional investor refers to the entity that pools money to purchase Achieve Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Long Focus Capital Management, Llc | 2025-03-31 | 248.1 K | Simplify Asset Management Inc. | 2025-03-31 | 217.8 K | Lpl Financial Corp | 2025-03-31 | 209.8 K | Goldman Sachs Group Inc | 2025-03-31 | 110.3 K | Charles Schwab Investment Management Inc | 2025-03-31 | 89.6 K | Renaissance Technologies Corp | 2025-03-31 | 87.9 K | Susquehanna International Group, Llp | 2025-03-31 | 80.7 K | Bank Of New York Mellon Corp | 2025-03-31 | 80.4 K | Wells Fargo & Co | 2025-03-31 | 74.3 K | Franklin Resources Inc | 2025-03-31 | 2.5 M | Propel Bio Management Llc | 2025-03-31 | 2.5 M |
Achieve Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Achieve Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Achieve Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Achieve Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Achieve Life Outstanding Bonds
Achieve Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Achieve Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Achieve bonds can be classified according to their maturity, which is the date when Achieve Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ACE INA HLDGS Corp BondUS00440EAH09 | View | |
| ACE INA HLDGS Corp BondUS00440EAQ08 | View | |
| ACE INA HLDGS Corp BondUS00440EAW75 | View | |
| ACE INA HLDGS Corp BondUS00440EAV92 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| ACI Worldwide 575 Corp BondUS004498AB73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| ACE CAP TR Corp BondUS00440FAA21 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.